ImmuPharma reports patent progress and new data for P140 autoimmune platform ImmuPharma shares rose on Friday after providing an update on P140, its autoimmune technology platform, pointing to progress on three…
AIM movers: ImmuPharma cash raising and CRISM Therapeutics orphan designation Africa-focused investment company Tapir Holdings (LON: TAPH) joined AIM on 11 March. Trading in the shares has been limited. Around…
Oriole Resources, Rainbow Rare Earths, Powerhouse Energy, ImmuPharma, Polarean Imaging, Vaultz Capital …